Shanghai OPM Biosciences Co (SHSE:688293) Change In Inventory: ¥0.0 Mil (TTM As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Shanghai OPM Biosciences Co Ltd SHSE:688293

71 GF Score

Price ¥57.48

GF Value ¥32.26

Valuation Significantly Overvalued

9 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Shanghai OPM Biosciences Co Change In Inventory?

Shanghai OPM Biosciences Co SHSE:688293 -3.12% 71 Change In Inventory is ¥0.0 Mil as of Mar. 2026. GuruFocus rates SHSE:688293 with a GF Score™ of 71/100 and a GF Value™ of ¥32.26 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Shanghai OPM Biosciences Co's change in inventory for the quarter that ended in Mar. 2026 was ¥0.0 Mil. It means Shanghai OPM Biosciences Co's inventory stayed the same from Dec. 2025 to Mar. 2026 .

Shanghai OPM Biosciences Co's change in inventory for the fiscal year that ended in Dec. 2025 was ¥-18.5 Mil. It means Shanghai OPM Biosciences Co's inventory increased by ¥18.5 Mil from Dec. 2024 to Dec. 2025 .

Shanghai OPM Biosciences Co's Total Inventories for the quarter that ended in Mar. 2026 was ¥179.1 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shanghai OPM Biosciences Co's Days Inventory for the quarter that ended in Mar. 2026 was 112.69.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shanghai OPM Biosciences Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.81.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shanghai OPM Biosciences Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.69.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Shanghai OPM Biosciences Co (SHSE:688293) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shanghai OPM Biosciences Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	126.448	/	102.393	*	365 / 4
	=	112.69

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shanghai OPM Biosciences Co's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	102.393	/	126.448
	=	0.81

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shanghai OPM Biosciences Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	126.448	/	182.155
	=	0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai OPM Biosciences Co Change In Inventory Related Terms

Shanghai OPM Biosciences Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Shanghai OPM Biosciences Co's Change In Inventory can be seen below:

Shanghai OPM Biosciences Co Change In Inventory Chart

Shanghai OPM Biosciences Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Inventory

Get a 7-Day Free Trial

-21.27

-10.56

-5.62

-9.41

-18.53

Shanghai OPM Biosciences Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Inventory	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

71GF Score

Shanghai OPM Biosciences Co Ltd SHSE:688293

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Shanghai OPM Biosciences Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of ¥0.0 Mil mean?

Shanghai OPM Biosciences Co (SHSE:688293) has a Change In Inventory of ¥0.0 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Shanghai OPM Biosciences Co and its competitors.

Is Shanghai OPM Biosciences Co's Change In Inventory too high?

Shanghai OPM Biosciences Co's current Change In Inventory is ¥0.0 Mil. Overall, Shanghai OPM Biosciences Co has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Shanghai OPM Biosciences Co's Change In Inventory compare to VRTX and REGN?

Shanghai OPM Biosciences Co's Change In Inventory of ¥0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Biotechnology company?

A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Shanghai OPM Biosciences Co and its competitors. Shanghai OPM Biosciences Co's current Change In Inventory is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shanghai OPM Biosciences Co stock overvalued right now?

Based on GuruFocus' analysis, Shanghai OPM Biosciences Co (SHSE:688293) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥32.26, compared to a current price of ¥57.48 — trading 78.2% above its estimated fair value. The current Change In Inventory is ¥0.0 Mil. Shanghai OPM Biosciences Co's overall GF Score™ is 71/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Shanghai OPM Biosciences Co (SHSE:688293), the current Change In Inventory is ¥0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai OPM Biosciences Co (SHSE:688293) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai OPM Biosciences Co stock appears to be overvalued. The current stock price of ¥57.48 is trading 78.2% above its estimated GF Value™ of ¥32.26. GuruFocus considers Shanghai OPM Biosciences Co to be Significantly Overvalued.

Key valuation signals for SHSE:688293:

Change In Inventory: ¥0.0 Mil
GF Value™: ¥32.26 vs. price of ¥57.48 (78.2% above fair value)
GF Score™: 71/100 with 9 warning signs

No single metric tells the full story. See the SHSE:688293 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →